Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptide
Aperçu rapide pour Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptide (ABIN1540907)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Séquence
- IREIKELNEL KDQIQDVEGK YMQGLKEMKD SLAEVEEKYK KAMVSNAQLD
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-Lrrfip1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Sujet
-
Lrrfip1 is a transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA
Alias Symbols: AU024550, Fliiap1
Protein Size: 428 -
Poids moléculaire
- 49 kDa
-
ID gène
- 16978
-
NCBI Accession
- NM_001111312, NP_001104782
-
UniProt
- G5E8E1
Antigène
-